经动脉化疗栓塞术联合槲芪散或槐耳颗粒治疗原发性肝癌的疗效对比分析  

Comparative analysis of therapeutic effect of huqisan and huaier particle in the treatment of patients with primary hepatocellular carcinoma after transeatheter arterial chemoembolization (TACE)

作　　者：陆青媛 

机构地区：[1]湖湘中医肿瘤医院,长沙市410011

出　　处：《实用医学杂志》2012年第18期3119-3120,共2页The Journal of Practical Medicine

摘　　要：目的:对比分析经动脉化疗栓塞术联合槲芪散或槐耳颗粒治疗原发性肝癌的临床疗效。方法:选取2009年8月至2010年5月我科收治的原发性肝癌患者85例作为研究对象,我们将上述患者随机分成两组,观察组43例,在经动脉化疗栓塞术后再给予槲芪散治疗;对照组42例,在经动脉化疗栓塞术后再给予槐耳颗粒治疗。口服槲芪散或槐耳颗粒的时间为期24周。结果:(1)治疗前,两组患者生存质量评分差异无统计学意义(P>0.05);治疗后,观察组生存质量评分显著大于对照组,两组比较差异有统计学意义(P<0.05)。(2)观察组的治疗有效率显著高于对照组,两组比较差异有统计学意义(P<0.05)。(3)观察组治疗后1年的生存率显著高于对照组,两组比较差异有统计学意义(P<0.05)。结论:经动脉化疗栓塞术后再联合使用槲芪散可以显著提高原发性肝癌患者的生存质量、治疗有效率、生存率等指标。Objective To comparatively analyze the therapeutic effect of huqisan and huaier particle in patients with primary hepatocellular carcinoma after TACE. Methods Eighty-five patients with primary hepatocellular carcinoma who were admitted into our department from August 2009 to May 2010 were divided into 2 groups, the observation group and control group, fourty-three patients in the observation group received huqisan for 24 weeks after TACE, and 42 patients in the control group received huaier particle for 24 weeks after TACE. Results Before treatment, there was no significant difference in quality-of-life score between the observation group and the control group （P 〉 0.05）. After treatment, the quality-of-life score of the observation group was signifieantly higher than that of the control group （P 〉 0.05）. The treatment efficiency and the survival rate of the observation group were significantly higher than that of the control group （P 〉 0.05）. Conclusion TACE combined with huqisan is able to improve the quality of life, the treatment efficiency, and the survival rate of patients with primary hepatocellular carcinoma.

关 键 词：肝肿瘤 经动脉化疗栓塞术 槲芪散 槐耳颗粒 原发性肝癌 

分 类 号：R735.7[医药卫生—肿瘤]